Last reviewed 2026-05-30 · How we verify

Benzoyl-Beta-Alanine (BETAMIPRON)

FDA-approved active Small molecule ✓ Verified May 2026 Quality 17/100

Benzoyl-Beta-Alanine (generic name: BETAMIPRON) is a betamipron drug. It is currently FDA-approved.

Benzoyl-Beta-Alanine is a small molecule with synonyms including BETAMIPRON, CS-443, and NSC-192714. Its exact mechanism and indications are not specified in the provided information from ChEMBL.

At a glance

Generic name	BETAMIPRON
Drug class	betamipron
Target	Solute carrier family 22 member 6, Solute carrier family 22 member 8
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Benzoyl-Beta-Alanine CI brief — competitive landscape report
Benzoyl-Beta-Alanine updates RSS · CI watch RSS

Frequently asked questions about Benzoyl-Beta-Alanine

What is Benzoyl-Beta-Alanine?

Benzoyl-Beta-Alanine (BETAMIPRON) is a betamipron drug.

What is the generic name of Benzoyl-Beta-Alanine?

BETAMIPRON is the generic (nonproprietary) name of Benzoyl-Beta-Alanine.

What drug class is Benzoyl-Beta-Alanine in?

Benzoyl-Beta-Alanine belongs to the betamipron class. See all betamipron drugs at /class/betamipron.

What development phase is Benzoyl-Beta-Alanine in?

Benzoyl-Beta-Alanine is FDA-approved (marketed).

What does Benzoyl-Beta-Alanine target?

Benzoyl-Beta-Alanine targets Solute carrier family 22 member 6, Solute carrier family 22 member 8 and is a betamipron.

Drug class: All betamipron drugs
Target: All drugs targeting Solute carrier family 22 member 6, Solute carrier family 22 member 8
Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing